The Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) research funding program from the National Institutes of Health supports multi-investigator, interdisciplinary team to develop integrated, transformative genomic approaches to address a biomedical problem. A CEGS project will address a critical issue in genomic science, genomic medicine, or computational genomics, proposing a highly innovative solution that would be a major advance. The research will entail substantial risk, balanced by outstanding scientific and management plans and very high potential payoff. A CEGS will focus on the development of novel technological or computational methods for the production or analysis of comprehensive data sets, on a genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems or furthering the application of genomic knowledge, data, and methods towards clinical applications. Each CEGS will nurture genomics by facilitating the interaction of investigators from several disciplines. Along with its scientific goals, CEGS will also expand the pool of genomic scientists and engineers that can use and apply the novel methods, concepts, and knowledge developed by the CEGS by providing education and outreach experiences to scientists at all career levels. Applications are open to US-based research institutions. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Applicants may apply for up to 1.5 million USD/year for up to 10 years.
Opportunity ID: PAR-23-098.
Letters of intent are due on May 21, 2024 and full applications are due on June 21, 2024.
June 21, 2024